Paracetamol PCD Pharma Franchise Company

Cafoli Lifecare is a leading Paracetamol PCD pharma franchise company in India, offering 106 Paracetamol formulations — the single largest molecule range in our portfolio. Products span tablets, syrup, suspension, oral drops, injection and IV infusion, including an extensive set of fixed-dose analgesic and cold combinations. All are manufactured at WHO-GMP certified, DCGI-approved facilities and offered with exclusive district-wise monopoly rights.

What is Paracetamol?

Paracetamol, known internationally as acetaminophen, is an analgesic and antipyretic. It acts centrally, principally by inhibiting prostaglandin synthesis within the central nervous system, which raises the pain threshold and acts on the hypothalamic heat-regulating centre to reduce fever. Unlike NSAIDs it has little peripheral anti-inflammatory effect and does not irritate the gastric mucosa or impair platelet function, which is why it is the preferred first-line antipyretic and analgesic across all age groups, including infants and pregnancy. It is listed on the WHO Model List of Essential Medicines.

Available Paracetamol Formulations

The Cafoli Lifecare Paracetamol range comprises 106 formulations in the following dosage forms:

• Tablets
• Syrup and Suspension
• Oral Drops (paediatric)
• Injection
• IV Infusion

Brand names, compositions, pack sizes and net rates are shared with registered franchise enquiries. Contact our team for the complete Paracetamol price list.

Therapeutic Applications of Paracetamol

Used under medical guidance for:

• Fever of any cause, in adults and children
• Mild to moderate pain — headache, myalgia, backache, toothache and dysmenorrhoea
• Osteoarthritic pain, where NSAIDs are unsuitable
• Post-operative and post-procedural pain, including as IV infusion
• Symptomatic relief in cold and influenza, in combination products
• Paediatric fever and pain, as drops, syrup or suspension

Prescriber specialties: general and consulting physicians, paediatricians, orthopaedic surgeons, dentists, gynaecologists, ENT specialists, surgeons and intensivists.

Safety note: Paracetamol is safe at recommended doses but is hepatotoxic in overdose, and the risk is compounded when several combination products containing it are taken together. Dosing instructions, particularly paediatric weight-based dosing, must be followed exactly as directed by the treating doctor.

Why Paracetamol is a High-Potential Molecule for Distributors

Paracetamol is the highest-volume pharmaceutical molecule in India, and the honest commercial picture has two halves. The plain tablet is a commodity — heavily competed, price-sensitive and thin on margin — but it is also the product that gets a franchise partner onto every chemist's shelf and into every doctor's prescription pad, because no one can practise without it. The profit is earned on the other hundred SKUs: paediatric drops and syrups, where parents want a brand they trust and substitution is far lower; cold-and-flu combinations, which carry better realisation and surge seasonally; and above all the IV infusion, a hospital product with high pack value, bulk institutional ordering and virtually no counter-level substitution. With 106 formulations, one monopoly allotment covers retail, paediatric, dental, surgical and hospital channels simultaneously. Handled well, Paracetamol is not a low-margin molecule — it is the widest door into a territory that exists.

Why Choose Cafoli Lifecare

• Monopoly rights — exclusive district-wise marketing rights across all 106 Paracetamol formulations
• WHO-GMP certified manufacturing and DCGI-approved products
• Promotional inputs — visual aids, MR bags, prescription pads, samples and reminder cards
• 1000+ franchise partners across India with an on-time dispatch record
• Transparent net rates and dedicated franchise support

References

1. WHO Model List of Essential Medicines
2. PubChem — Paracetamol (acetaminophen) compound record
3. MedlinePlus — Acetaminophen (Paracetamol)